Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Fully Vaccinated Individuals at Risk for COVID Infection With Omicron Variant – Columbia Study
    Health

    Fully Vaccinated Individuals at Risk for COVID Infection With Omicron Variant – Columbia Study

    By Columbia University Irving Medical CenterDecember 24, 20213 Comments5 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    SARS-CoV-2 Transmission Electron Microscope
    This transmission electron microscope image shows SARS-CoV-2— the virus that causes COVID-19—isolated from a patient in the U.S. Virus particles are shown emerging from the surface of cells cultured in the lab. The spikes on the outer edge of the virus particles give coronaviruses their name, crown-like. Credit: NIAID RML

    New Study Adds More Evidence for Omicron Immune Evasion

    Results suggest that previously infected individuals and fully vaccinated individuals are at risk for COVID-19 infection with the omicron variant, and omicron is completely resistant to all antibodies in clinical use today.

    A new study from Columbia researchers, in collaboration with scientists at the University of Hong Kong, adds more evidence that the COVID-19 omicron variant can evade the immune protection conferred by vaccines and natural infection and suggests the need for new vaccines and treatments that anticipate how the virus may soon evolve.

    The findings were published on December 23, 2021, in the journal Nature by David Ho, MD, director of the Aaron Diamond AIDS Research Center and the Clyde’56 and Helen Wu Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons.

    “It is not too far-fetched to think that SARS-CoV-2 is now only a mutation or two away from being completely resistant to current antibodies.”

    A striking feature of the omicron variant is the alarming number of changes in the virus’s spike protein that could pose a threat to the effectiveness of current vaccines and therapeutic antibodies.

    Large drop in omicron neutralization by antibodies from vaccines

    The new study tested the ability of antibodies generated by vaccination to neutralize the omicron variant in laboratory assays that pitted antibodies against live viruses and against pseudoviruses constructed in the lab to mimic omicron.

    Antibodies from people double-vaccinated with any of the four most widely used vaccines—Moderna, Pfizer, AstraZeneca, Johnson & Johnson—were significantly less effective at neutralizing the omicron variant compared to the ancestral virus. Antibodies from previously infected individuals were even less likely to neutralize omicron.

    “Even a third booster shot may not adequately protect against omicron infection, but of course it is advisable to get one, as you’ll still benefit from some immunity.”

    Individuals who received a booster shot of either of the two mRNA vaccines are likely to be better protected, although even their antibodies exhibited diminished neutralizing activity against omicron.

    “The new results suggest that previously infected individuals and fully vaccinated individuals are at risk for infection with the omicron variant,” says Ho. “Even a third booster shot may not adequately protect against omicron infection, but of course it is advisable to get one, as you’ll still benefit from some immunity.”

    The results are consistent with other neutralization studies, as well as early epidemiological data from South Africa and the U.K., which show efficacy of two doses of the vaccines against symptomatic disease is significantly reduced against the omicron variant.

    Ho’s lab also identified four new spike mutations in omicron that help the virus evade antibodies.

    Most monoclonal antibodies are unable to neutralize omicron

    When administered early in the course of infection, monoclonal antibodies can prevent many individuals from developing severe COVID. But the new study suggests that all of the therapies currently in use and most in development are much less effective against omicron, if they work at all.

    In neutralization studies with monoclonal antibodies, only one (Brii198 approved in China) maintained notable activity against omicron. A minor form of omicron is completely resistant to all antibodies in clinical use today. The authors note that omicron is now the most complete “escapee” from neutralization that scientists have seen.

    In this study Ho’s lab also identified four new spike mutations in omicron that help the virus evade antibodies. This information should inform the design of new approaches to combat the new variant.

    Future directions

    Ho suggests that scientists will need to develop vaccines and treatments that can better anticipate how the virus is evolving.

    “It is not too far-fetched to think that SARS-CoV-2 is now only a mutation or two away from being completely resistant to current antibodies, either the monoclonal antibodies used as therapies or the antibodies generated by vaccination or infection with previous variants,” says Ho.

    Reference: “Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2” by Lihong Liu, Sho Iketani, Yicheng Guo, Jasper F-W. Chan, Maple Wang, Liyuan Liu, Yang Luo, Hin Chu, Yiming Huang, Manoj S. Nair, Jian Yu, Kenn K-H. Chik, Terrence T-T. Yuen, Chaemin Yoon, Kelvin K-W. To, Honglin Chen, Michael T. Yin, Magdalena E. Sobieszczyk, Yaoxing Huang, Harris H. Wang, Zizhang Sheng, Kwok-Yung Yuen and David D. Ho, 23 December 2021, Nature.
    DOI: 10.1038/d41586-021-03826-3
    bioRxiv

    The full list of contributors is available in the online version of the paper.

    David Ho and some of his colleagues are inventors of certain monoclonal antibodies described in the paper.

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Antibodies Columbia University Columbia University Irving Medical Center COVID-19 Immunology Infectious Diseases Popular Vaccine Virology
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Structural Changes Identified in COVID Alpha and Beta Variants – Suggests Need for Updated Vaccine Booster

    Antibody Binding-Site Conserved Across COVID-19 Virus Variants – Big Implications for Future Vaccines

    Experts Warn: Vaccines Alone May Not Be Enough to End COVID-19 Pandemic

    Dire Coronavirus Prediction: Virus Evolving to Escape Current Vaccines, Treatments – “May Be Condemned to Chasing After the Evolving SARS-CoV-2 Continually”

    Immune Boosting Nasal Spray: Protects Against COVID-19, Is Also Effective Against the Common Cold

    Nasal Spray May Prevent Coronavirus Infection in People Exposed to COVID-19

    SARS-CoV-2 Antibodies Provide Lasting COVID-19 Immunity

    Potent Neutralizing Antibodies Isolated From COVID-19 Patients – Could Be Mass-Produced to Suppress Virus

    Common Molecular Feature of Antibodies That Neutralize SARS-CoV-2 Discovered, Boosting COVID-19 Vaccine Prospects

    3 Comments

    1. Howard Jeffrey Bender, Ph.D. on December 25, 2021 6:02 am

      All the coronaviruses and all their variants have different protein spikes, with Delta and Omicron having spikes that are more efficient at getting around the vaccines. But the real problem is in the virus itself, not its protein shell, and why the most dangerous (MERS, SARS, and Covid-19) are so infectious. My independent research has found multiple one-in-a-million nucleotide sequence matches between all the coronaviruses and the human genome. Those sequences are the same as some of the loops of human tRNA. Using those loops and their amino acid code matches, viruses may be able to fool the nucleus membrane in cells to allow the virus to enter and associate with the human DNA, creating more opportunities for further infection. Our immune system may be compromised and may no longer be able to stop the virus and other diseases from attacking organs throughout the body. Vaccines that attack the virus protein shells while ignoring their contents are doomed to failure from the Darwin effect, but recognizing these loops suggests a possible approach to successful coronavirus vaccines. Only the infection process is considered in my work, not the innate virulence of the virus. For more info, check out this YouTube, Coronavirus – Using Your DNA Against You. https://www.youtube.com/watch?v=8dOIzD6ch8s

      Reply
    2. Claire on December 25, 2021 12:12 pm

      The ongoing COVID-19 nonsense here in the United States exists solely and exclusively because our governments have failed to use the correct treatment. They used so-called “vaccines” when Japan has just proven, in less than ONE MONTH, that Ivermectin can wipe out the disease. IVM was awarded the Nobel prize for medicine in 2015. One of the 3 most important drugs in human history: Aspirin, Penicillin, and Ivermectin. Get your Ivermectin today while you still can! https://medicalfreedom.wiki/

      Reply
    3. Ankh on December 25, 2021 6:12 pm

      https://apnews.com/article/fact-checking-079183409501

      Reply
    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Scientists Uncover Potential Brain Risks of Popular Fish Oil Supplements

    Scientists Discover a Surprising Way To Make Bread Healthier and More Nutritious

    After 60 Years, Scientists Uncover Unexpected Brain Effects of Popular Diabetes Drug Metformin

    New Research Uncovers Hidden Side Effects of Popular Weight-Loss Drugs

    Scientists Rethink Extreme Warming After Surprising Ocean Discovery

    Landmark Study Links Never Marrying to Significantly Higher Cancer Risk

    Researchers Discover Unknown Beetle Species Just Steps From Their Lab

    Largest-Ever Study Finds Medicinal Cannabis Ineffective for Anxiety, Depression, PTSD

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Not Just Alzheimer’s: Scientists Uncover Clues to a Second, Overlooked Disorder
    • Scientists Uncover Dangerous Connection Between Serotonin and Heart Valve Disease
    • Scientists Discover a “Protector” Protein That Could Help Reverse Hair Loss
    • Powerful Lasers Reveal How Matter Becomes Plasma in Trillionths of a Second
    • A Simpler Path to Super-Resolution: Scientists Reinvent Microscopy
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.